about
PET probes beyond (18)F-FDGImaging Mass Spectrometry Revealed the Accumulation Characteristics of the 2-Nitroimidazole-Based Agent "Pimonidazole" in HypoxiaImaging Reactive Oxygen Species-Induced Modifications in Living Systems.Ischaemic penumbra: highlights.Redox- and hypoxia-responsive MRI contrast agents.Hypoxia-specific ultrasensitive detection of tumours and cancer cells in vivo.[18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility studypO polarography, contrast enhanced color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography: validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the puThe concept of the penumbra: can it be translated to stroke management?Synthesis and in vitro and in vivo evaluation of hypoxia-enhanced 111In-bombesin conjugates for prostate cancer imaging.Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxiaHypoxia in head and neck cancer in theory and practice: a PET-based imaging approachImaging of hypoxic-ischemic penumbra with (18)F-fluoromisonidazole PET/CT and measurement of related cerebral metabolism in aneurysmal subarachnoid hemorrhage.1,2-Bis[2-(2-nitro-1H-imidazol-1-yl)eth-oxy]ethane.Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PETMicroneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery4-(2-{2-[2-(2-Nitro-1H-imidazol-1-yl)ethoxy]eth-oxy}eth-oxy)benzaldehyde.18F-FAZA PET imaging response tracks the reoxygenation of tumors in mice upon treatment with the mitochondrial complex I inhibitor BAY 87-2243Dynamic oxygenation measurements using a phosphorescent coating within a mammary window chamber mouse model.Combined use of (18)F-FDG and (18)F-FMISO in unresectable non-small cell lung cancer patients planned for radiotherapy: a dynamic PET/CT study.Nitroimidazole conjugates of bis(thiosemicarbazonato)64Cu(II) - Potential combination agents for the PET imaging of hypoxia.Assessing tumor hypoxia by positron emission tomography with Cu-ATSMMeasurement of hypoxia-related parameters in three sublines of a rat prostate carcinoma using dynamic (18)F-FMISO-Pet-Ct and quantitative histology.Detailed assessment of gene activation levels by multiple hypoxia-responsive elements under various hypoxic conditions.Development of hypoxia enhanced 111In-labeled Bombesin conjugates: design, synthesis, and in vitro evaluation in PC-3 human prostate cancer.Stroma targeting nuclear imaging and radiopharmaceuticals.BMS181321 accumulation in rodent and human cells: the role of P-glycoprotein.A simplified synthesis of the hypoxia imaging agent 2-(2-Nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-[(18)F]pentafluoropropyl)-acetamide ([18F]EF5)Positron emission tomography (PET), immuno-PET and radioimmunotherapy in renal cell carcinoma: a developing diagnostic and therapeutic relationship.In vivo evaluation of [18F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomographyTargeting tumor hypoxia with 2-nitroimidazole-indocyanine green dye conjugates.Autoradiographic and small-animal PET comparisons between (18)F-FMISO, (18)F-FDG, (18)F-FLT and the hypoxic selective (64)Cu-ATSM in a rodent model of cancer.Light-Activated Hypoxia-Responsive Nanocarriers for Enhanced Anticancer Therapy.Examining the relationship between Cu-ATSM hypoxia selectivity and fatty acid synthase expression in human prostate cancer cell lines.Positron Emission Tomography Imaging of Hypoxia.PET in Cerebrovascular Disease.PET-CT for radiotherapy treatment planning and response monitoring in solid tumors.Techniques of assessing hypoxia at the bench and bedside.PET imaging of cardiac hypoxia: opportunities and challenges.Molecular Imaging of Hypoxia: Strategies for Probe Design and Application.
P2860
Q27004457-62D71ECE-8745-482A-B7BB-131CA7FD3138Q28553813-77ACA8EA-AA1A-4225-9A44-6FD646A61C83Q30381432-FE4D1310-D498-49E8-9BDE-19110D67A876Q30749047-3D1ABF53-BA17-46F3-8948-FE6CD7590A2EQ30820031-BB23A22C-1180-42A6-AF6B-35129D53FD04Q30882619-1744ED0B-989A-4067-915F-C5E9331FAAA2Q33235431-D843AA2F-45B0-498C-97DC-E74196B165A3Q33289243-B5BC5FB5-504B-4F38-A676-7BB25FA9B59EQ33634503-BBC218D2-51F8-434D-BCC7-04AE1F45ED30Q33725998-4E32F487-4ED1-4D84-BB29-2DF2268C8F10Q33798508-5B6950C6-240A-4DD0-AA9E-80AE4E3CBE68Q34151551-1C4DD9B0-9266-4412-8A01-2A205C1C25D3Q34170743-8A1B7BC5-4AE8-466D-AE3C-5DCF7484CD3EQ34226724-8E83845C-E70D-4EB3-A921-4E1CD96EE367Q34235986-7B6A6CCC-3AAA-421E-922C-10670DC9732EQ34481917-2C7B65C1-A065-4DDE-9EE5-44900552D7C3Q34945361-CA7AFBBC-92A6-45D4-B906-AAC03D700176Q34979821-C85691AC-C847-49CF-9806-A540B6AB6DE9Q35162094-D242F63E-75B7-476F-9951-352318214D93Q35402102-3FAE1877-29F8-41A5-87D4-6C9FDF22F524Q35545523-A73753E1-49ED-418D-BEA2-404700799AA0Q35565683-8EED29E1-9A27-4FB5-8923-133C28FA1503Q35744761-24A13FB5-F025-4D31-96A0-4FEE8FCBD98DQ35789454-E4CF9C55-4AA8-4F44-8527-9A07781D1B19Q35846757-AC512876-A6F5-492C-B359-FD993952C7F3Q35999606-F73FBFC0-06B1-445B-BE60-D510C3B0E04CQ36291908-3832A7B3-002A-4360-8D47-A9C8F232CB77Q36340165-754850C3-09BA-491E-832B-70C37F8912AAQ36462104-F636A9C1-D56E-46C6-A257-8FD66BD4B857Q36694230-6CF887F5-9C72-4442-B354-CC62070F1BD9Q36923843-65FC8A95-537A-4FAF-9293-90769096B272Q37140996-CEF0FE4F-D203-44CD-B263-C36099FC94B0Q37206887-31C5443C-055D-4FC3-B6D1-764CBD422FEDQ37414432-6F046988-D04C-4CDE-B157-08D13A0148FEQ37666742-FB9C0B37-FCC6-43E4-B965-F69B46C510CDQ37764708-76EA8E27-98AE-466F-9CD4-54CC2FE0020AQ37832131-8179A9C5-0CC6-4610-9781-1DD5EA459423Q37843729-1A0251D6-5C4B-4DE2-8976-B4F84593FE4DQ37904019-D0BCBE85-5D61-42AF-851F-B222D6EBB6B8Q37986039-47950B93-A36D-436F-B0D0-D4AB61D114A1
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Nitroimidazoles and imaging hypoxia.
@en
type
label
Nitroimidazoles and imaging hypoxia.
@en
prefLabel
Nitroimidazoles and imaging hypoxia.
@en
P2093
P356
P1476
Nitroimidazoles and imaging hypoxia.
@en
P2093
P2888
P304
P356
10.1007/BF01081524
P577
1995-03-01T00:00:00Z